CYTOKINETICS, INCORPORATED Investment Income, Interest
CYTOKINETICS, INCORPORATED (CYTK) reported Investment Income, Interest of $11.40 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2023-03-01
- CYTOKINETICS, INCORPORATED investment income, interest for the quarter ending 2022-12-31 was $6.00M, a 1900.00% increase year-over-year.
- CYTOKINETICS, INCORPORATED investment income, interest for the quarter ending 2022-09-30 was $4.10M, a 1950.00% increase year-over-year.
- CYTOKINETICS, INCORPORATED investment income, interest for the quarter ending 2022-06-30 was $900.00K, a 350.00% increase year-over-year.
- CYTOKINETICS, INCORPORATED investment income, interest for the quarter ending 2022-03-31 was $400.00K, a 33.33% increase year-over-year.
- CYTOKINETICS, INCORPORATED investment income, interest for fiscal 2022 was $11.40M, a 1040.00% increase from fiscal 2021.
- CYTOKINETICS, INCORPORATED investment income, interest for fiscal 2021 was $1.00M, a 81.13% decline from fiscal 2020.
- CYTOKINETICS, INCORPORATED investment income, interest for fiscal 2020 was $5.30M, a 17.78% increase from fiscal 2019.
- CYTOKINETICS, INCORPORATED investment income, interest for fiscal 2019 was $4.50M, a 7.14% increase from fiscal 2018.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed | Investment Income, Interest 185 month | Investment Income, Interest 188 month | Investment Income, Interest 191 month | Investment Income, Interest 194 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $10.10M derived: sum of 2 quarters · filed 2023-03-01 | $11.00M derived: sum of 3 quarters · filed 2023-03-01 | $11.40M 10-K · filed 2023-03-01 | ||||||||
| 2022-09-30 | $4.10M 10-Q · filed 2022-11-04 | $5.00M derived: sum of 2 quarters · filed 2022-11-04 | $5.40M 10-Q · filed 2022-11-04 | $5.70M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||
| 2022-06-30 | $900.00K 10-Q · filed 2022-08-05 | $1.30M 10-Q · filed 2022-08-05 | $1.60M derived: sum of 3 quarters · filed 2023-03-01 | $1.80M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||
| 2022-03-31 | $400.00K 10-Q · filed 2022-05-06 | $700.00K derived: sum of 2 quarters · filed 2023-03-01 | $900.00K derived: sum of 3 quarters · filed 2023-03-01 | $1.10M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||
| 2021-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $500.00K derived: sum of 2 quarters · filed 2023-03-01 | $700.00K derived: sum of 3 quarters · filed 2023-03-01 | $1.00M 10-K · filed 2023-03-01 | ||||||||
| 2021-09-30 | $200.00K 10-Q · filed 2022-11-04 | $400.00K derived: sum of 2 quarters · filed 2022-11-04 | $700.00K 10-Q · filed 2022-11-04 | $2.80M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||
| 2021-06-30 | $200.00K 10-Q · filed 2022-08-05 | $500.00K 10-Q · filed 2022-08-05 | $2.60M derived: sum of 3 quarters · filed 2023-03-01 | $3.70M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||
| 2021-03-31 | $300.00K 10-Q · filed 2022-05-06 | $2.40M derived: sum of 2 quarters · filed 2023-03-01 | $3.50M derived: sum of 3 quarters · filed 2023-03-01 | $4.90M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||
| 2020-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $3.20M derived: sum of 2 quarters · filed 2023-03-01 | $4.60M derived: sum of 3 quarters · filed 2023-03-01 | $5.30M 10-K · filed 2023-03-01 | ||||||||
| 2020-09-30 | $1.10M 10-Q · filed 2021-11-05 | $2.50M derived: sum of 2 quarters · filed 2021-11-05 | $3.20M 10-Q · filed 2021-11-05 | $4.50M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||
| 2020-06-30 | $1.40M 10-Q · filed 2021-08-06 | $2.10M 10-Q · filed 2021-08-06 | $3.40M derived: sum of 3 quarters · filed 2022-02-25 | $4.40M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||
| 2020-03-31 | $700.00K 10-Q · filed 2021-05-07 | $2.00M derived: sum of 2 quarters · filed 2022-02-25 | $3.00M derived: sum of 3 quarters · filed 2022-02-25 | $4.00M derived: sum of 4 quarters · filed 2022-02-25 | ||||||||
| 2019-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $2.30M derived: sum of 2 quarters · filed 2022-02-25 | $3.30M derived: sum of 3 quarters · filed 2022-02-25 | $4.50M 10-K · filed 2022-02-25 | ||||||||
| 2019-09-30 | $1.00M 10-Q · filed 2019-11-01 | $2.00M derived: sum of 2 quarters · filed 2019-11-01 | $3.20M 10-Q · filed 2019-11-01 | $4.00M derived: sum of 4 quarters · filed 2020-03-04 | ||||||||
| 2019-06-30 | $1.00M 10-Q · filed 2019-08-09 | $2.20M 10-Q · filed 2019-08-09 | $3.00M derived: sum of 3 quarters · filed 2020-03-04 | $4.30M derived: sum of 4 quarters · filed 2020-03-04 | ||||||||
| 2019-03-31 | $1.10M 10-Q · filed 2019-05-09 | $2.00M derived: sum of 2 quarters · filed 2020-03-04 | $3.30M derived: sum of 3 quarters · filed 2020-03-04 | $4.40M derived: sum of 4 quarters · filed 2020-03-04 | ||||||||
| 2018-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $2.20M derived: sum of 2 quarters · filed 2020-03-04 | $3.30M derived: sum of 3 quarters · filed 2020-03-04 | $4.20M 10-K · filed 2020-03-04 | ||||||||
| 2018-09-30 | $1.30M 10-Q · filed 2019-11-01 | $2.40M derived: sum of 2 quarters · filed 2019-11-01 | $3.30M 10-Q · filed 2019-11-01 | |||||||||
| 2018-06-30 | $1.10M 10-Q · filed 2019-08-09 | $2.00M 10-Q · filed 2019-08-09 | ||||||||||
| 2018-03-31 | $800.00K 10-Q · filed 2019-05-09 | |||||||||||
| 2017-09-30 | $800.00K 10-Q · filed 2018-11-09 | $774.00K 10-Q · filed 2017-11-03 | $1.40M derived: sum of 2 quarters · filed 2018-11-09 | $1.80M 10-Q · filed 2018-11-09 | $1.96M 10-Q · filed 2017-11-03 | $1.67M derived: sum of 4 quarters · filed 2018-11-09 | ||||||
| 2017-06-30 | $600.00K 10-Q · filed 2018-08-07 | $694.00K 10-Q · filed 2017-08-04 | $1.00M 10-Q · filed 2018-08-07 | $1.18M 10-Q · filed 2017-08-04 | $867.00K derived: sum of 3 quarters · filed 2018-08-07 | $981.00K derived: sum of 4 quarters · filed 2018-08-07 | ||||||
| 2017-03-31 | $100.00K 10-Q · filed 2018-05-10 | $489.00K 10-Q · filed 2017-05-04 | $267.00K derived: sum of 2 quarters · filed 2018-05-10 | $381.00K derived: sum of 3 quarters · filed 2018-05-10 | $486.00K derived: sum of 4 quarters · filed 2018-05-10 | |||||||
| 2016-12-31 | $167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $281.00K derived: sum of 2 quarters · filed 2017-11-03 | $386.00K derived: sum of 3 quarters · filed 2017-11-03 | $449.00K 10-K · filed 2017-03-06 | ||||||||
| 2016-09-30 | $114.00K 10-Q · filed 2017-11-03 | $219.00K derived: sum of 2 quarters · filed 2017-11-03 | $282.00K 10-Q · filed 2017-11-03 | $323.00K derived: sum of 4 quarters · filed 2017-11-03 | ||||||||
| 2016-06-30 | $105.00K 10-Q · filed 2017-08-04 | $168.00K 10-Q · filed 2017-08-04 | $209.00K derived: sum of 3 quarters · filed 2017-08-04 | $247.00K derived: sum of 4 quarters · filed 2017-08-04 | ||||||||
| 2016-03-31 | $62.00K 10-Q · filed 2017-05-04 | $104.00K derived: sum of 2 quarters · filed 2017-05-04 | $142.00K derived: sum of 3 quarters · filed 2017-05-04 | $180.00K derived: sum of 4 quarters · filed 2017-05-04 | ||||||||
| 2015-12-31 | $42.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-03-06 | $80.00K derived: sum of 2 quarters · filed 2017-03-06 | $118.00K derived: sum of 3 quarters · filed 2017-03-06 | $156.00K 10-K · filed 2017-03-06 | ||||||||
| 2015-09-30 | $38.00K 10-Q/A · filed 2016-12-15 | $76.00K derived: sum of 2 quarters · filed 2016-12-15 | $114.00K 10-Q/A · filed 2016-12-15 | $136.00K derived: sum of 4 quarters · filed 2017-03-06 | ||||||||
| 2015-06-30 | $38.00K 10-Q · filed 2016-08-04 | $75.00K 10-Q · filed 2016-08-04 | $98.00K derived: sum of 3 quarters · filed 2017-03-06 | $124.00K derived: sum of 4 quarters · filed 2017-03-06 | ||||||||
| 2015-03-31 | $37.00K 10-Q · filed 2016-05-05 | $60.00K derived: sum of 2 quarters · filed 2017-03-06 | $86.00K derived: sum of 3 quarters · filed 2017-03-06 | $112.00K derived: sum of 4 quarters · filed 2017-03-06 | ||||||||
| 2014-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $49.00K derived: sum of 2 quarters · filed 2017-03-06 | $75.00K derived: sum of 3 quarters · filed 2017-03-06 | $101.00K 10-K · filed 2017-03-06 | ||||||||
| 2014-09-30 | $26.00K 10-Q · filed 2015-11-05 | $52.00K derived: sum of 2 quarters · filed 2015-11-05 | $78.00K 10-Q · filed 2015-11-05 | $100.00K derived: sum of 4 quarters · filed 2016-03-03 | ||||||||
| 2014-06-30 | $26.00K 10-Q · filed 2015-08-05 | $52.00K 10-Q · filed 2015-08-05 | $74.00K derived: sum of 3 quarters · filed 2016-03-03 | $97.00K derived: sum of 4 quarters · filed 2016-03-03 | ||||||||
| 2014-03-31 | $26.00K 10-Q · filed 2015-05-04 | $48.00K derived: sum of 2 quarters · filed 2016-03-03 | $71.00K derived: sum of 3 quarters · filed 2016-03-03 | $94.00K derived: sum of 4 quarters · filed 2016-03-03 | ||||||||
| 2013-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $45.00K derived: sum of 2 quarters · filed 2016-03-03 | $68.00K derived: sum of 3 quarters · filed 2016-03-03 | $96.00K 10-K · filed 2016-03-03 | $792.00K 10-K · filed 2014-03-07 | |||||||
| 2013-09-30 | $23.00K 10-Q · filed 2014-11-06 | $46.00K derived: sum of 2 quarters · filed 2014-11-06 | $74.00K 10-Q · filed 2014-11-06 | $105.00K derived: sum of 4 quarters · filed 2015-03-06 | $28.68M 10-Q · filed 2013-11-06 | |||||||
| 2013-06-30 | $23.00K 10-Q · filed 2014-08-07 | $51.00K 10-Q · filed 2014-08-07 | $82.00K derived: sum of 3 quarters · filed 2015-03-06 | $112.00K derived: sum of 4 quarters · filed 2015-03-06 | $28.66M 10-Q · filed 2013-08-07 | |||||||
| 2013-03-31 | $28.00K 10-Q · filed 2014-05-07 | $59.00K derived: sum of 2 quarters · filed 2015-03-06 | $89.00K derived: sum of 3 quarters · filed 2015-03-06 | $97.00K derived: sum of 4 quarters · filed 2015-03-06 | $28.64M 10-Q · filed 2013-05-08 | |||||||
| 2012-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06 | $61.00K derived: sum of 2 quarters · filed 2015-03-06 | $69.00K derived: sum of 3 quarters · filed 2015-03-06 | $83.00K 10-K · filed 2015-03-06 | $28.61M 10-K · filed 2013-03-15 | |||||||
| 2012-09-30 | $30.00K 10-Q · filed 2013-11-06 | $38.00K derived: sum of 2 quarters · filed 2013-11-06 | $52.00K 10-Q · filed 2013-11-06 | $70.00K derived: sum of 4 quarters · filed 2014-03-07 | ||||||||
| 2012-06-30 | $8.00K 10-Q · filed 2013-08-07 | $22.00K 10-Q · filed 2013-08-07 | $40.00K derived: sum of 3 quarters · filed 2014-03-07 | $76.00K derived: sum of 4 quarters · filed 2014-03-07 | ||||||||
| 2012-03-31 | $14.00K 10-Q · filed 2013-05-08 | $32.00K derived: sum of 2 quarters · filed 2014-03-07 | $68.00K derived: sum of 3 quarters · filed 2014-03-07 | $95.00K derived: sum of 4 quarters · filed 2014-03-07 | ||||||||
| 2011-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $54.00K derived: sum of 2 quarters · filed 2014-03-07 | $81.00K derived: sum of 3 quarters · filed 2014-03-07 | $132.00K 10-K · filed 2014-03-07 | ||||||||
| 2011-09-30 | $36.00K 10-Q · filed 2012-11-07 | $63.00K derived: sum of 2 quarters · filed 2012-11-07 | $114.00K 10-Q · filed 2012-11-07 | |||||||||
| 2011-06-30 | $27.00K 10-Q · filed 2012-08-06 | $78.00K 10-Q · filed 2012-08-06 | ||||||||||
| 2010-12-31 | $318.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |